“…Moreover, we have noted that patients who are affected by chronic, non-communicable diseases have a higher risk of a fatal outcome from coronavirus SARS-2 infection. The impact of the virus has been particularly severe among those suffering from chronic viral hepatitis, widening the spectrum of viruses that hepatologists need to prioritize [13] , [14] , [15] , [16] . Additionally, it is important to bear in mind that these viruses affect patients differently [17] .…”